Specifically, no difference was detected in 90-day mortality for patients with SSI due to MRSA who received appropriate antimicrobial therapy compared with patients with SSI due to MSSA who received appropriate antimicrobial therapy.
Specifically, no difference was reported in the rate of cardiovascular events (6 events were reported: 3 in the allopurinol arm and 3 in the febuxostat 80 mg/day group).
Specifically, no difference was reported in the rate of cardiovascular events (six events were reported: three in the allopurinol arm and three in the febuxostat 80 mg/day group).
Specifically, no differences in tumor initiation or its growth rate were detected between the two groups throughout the two weeks of measurements (Fig. 3a).
Specifically, no differences were found for the following scales: Injury Severity Score (ISS), Glasgow Coma Scale (GCS), Impact of Event Scale (IES), appraisal of coping abilities.
When further analyzing the dropout in the index group specifically, no differences were found regarding gender, mother's life stress score or earlier emotional and behavior problems among the children at the age of 3 between participants and dropouts.
Specifically, no survival difference was observed between G3 mTerc -/- Sod2+/- mice compared to G3 mTerc -/-, Sod2+/+ mice (median lifespan 72.3 and 69.1 weeks respectively, p=0.75 Figure 4A).
However, we specifically could find no difference in consumption of carotenes or tocopherol (p = 0.85 and 0.2 respectively) between cases and controls, two of the validated nutrient factors found in our EWAS (Table 1).
Specifically, there was no difference in the frequency or distribution of severity of postoperative outcomes.
Specifically, there was no difference in the rate of falls following a change to a SSRI versus non-SSRI antidepressant (11.9 versus 14.4 falls/1,000 person years; p = 0.58), a typical versus an atypical antipsychotic (25.4 versus 17.1 falls/1,000 person years; p = 0.10), or a short versus long acting benzodiazepine (15.2 versus 13.9 falls/1,000 person years; p = 0.23).
Specifically, no statistically significant differences were observed for combined measures of adiposity for dietary interventions (SMD, -0.22, 95% CI, -0.56 to 0.11) while a statistically significant improvement was observed for combined lifestyle interventions targeting the family (SMD, -0.64, 95% CI, -0.88 to -0.39) but not children (SMD, -0.17, 95% CI, -0.40 to 0.05) [ 19].
